-
After 20 years and $200 billion in revenue, Humira — an injectable treatment for autoimmune conditions like rheumatoid arthritis — is losing its monopoly.
-
Evidence is mounting that doctors who receive as little as one meal from a drug company tend to prescribe more expensive, brand-name medications for…
-
Believe it or not, it may be cheaper to pay for a prescription yourself rather than using your insurance. And if that fails, there are other places to turn for help getting the best possible deal.
-
Drugs made from proteins or antibodies are difficult for rival manufacturers to copy. The Food and Drug Administration just approved a copycat drug for cancer patients that shows it can be done.